Evaluación económica de medicamentos: experiencias y vías de avance. Una visión complementaria

Oliva Moreno, Juan; Bernal Delgado, Enrique; Puig i Junoy, Jaume

doi:http://dx.doi.org/10.1157/13125359

Evaluación económica de medicamentos: experiencias y vías de avance. Una visión complementaria

License

Citation

Oliva J, Puig-Junoy J, Bernal E. Evaluación económica de medicamentos: experiencias y vías de avance. Una visión complementaria. Gac Sanit. 2008;22(4):358-61. DOI: 10.1157/13125359

Abstract

This article presents a complementary view of the latest experiences and advances in the economic evaluation of medicines in the Spanish market. The European context and recent normative changes seem to favour the incorporation of economic evaluation of medicines as a basic tool in the decision-making process of public funding of drugs. However, some doubts remain about whether government support for economic evaluation of medicines will be open and explicit and about the role that regional decision-makers and other health actors will play in this process.